DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Nephrocare Health Services Limited — Credit Rating- Revision

NSE 1 hr ago·18 Sept 2026, 3:26 pm

Nephrocare Health Serv L

Nephrocare Health Services Limited has informed exchanges that its credit rating has been revised. This change reflects an updated assessment of the company's financial health and ability to meet its future obligations.

For investors, a credit rating is a key indicator of a firm's creditworthiness. A revision signals that the rating agency has reassessed the company's risk profile, which can influence how lenders and other stakeholders view the company's stability and borrowing capacity.

Investors should review the specific details of the rating revision to understand the reasons behind the change. It is important to monitor the company's future financial performance and any related disclosures to gauge the impact on its operations and long-term outlook.